These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 14748202)

  • 61. PROGRESS (Perindopril Protection Against Recurrent Stroke Study): regional characteristics of the study population at baseline. PROGRESS Management Committee.
    Chalmers J; Neal B; MacMahon S;
    J Hypertens Suppl; 2000 May; 18(1):S13-9. PubMed ID: 10939785
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Rationale and design of a randomized, double-blind, placebo-controlled trial of ivabradine in patients with stable coronary artery disease and left ventricular systolic dysfunction: the morBidity-mortality EvAlUaTion of the I(f) inhibitor ivabradine in patients with coronary disease and left ventricULar dysfunction (BEAUTIFUL) study.
    Fox K; Ferrari R; Tendera M; Steg PG; Ford I;
    Am Heart J; 2006 Nov; 152(5):860-6. PubMed ID: 17070146
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Not all angiotensin-converting enzyme inhibitors are equal: focus on ramipril and perindopril.
    Dinicolantonio JJ; Lavie CJ; O'Keefe JH
    Postgrad Med; 2013 Jul; 125(4):154-68. PubMed ID: 23933903
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Are angiotensin-converting enzyme inhibitors and angiotensin receptor blockers especially useful for cardiovascular protection?
    Ong HT
    J Am Board Fam Med; 2009; 22(6):686-97. PubMed ID: 19897698
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Effect of ramipril in reducing sudden deaths and nonfatal cardiac arrests in high-risk individuals without heart failure or left ventricular dysfunction.
    Teo KK; Mitchell LB; Pogue J; Bosch J; Dagenais G; Yusuf S;
    Circulation; 2004 Sep; 110(11):1413-7. PubMed ID: 15353497
    [TBL] [Abstract][Full Text] [Related]  

  • 66. PROGRESS--perindopril protection against recurrent stroke study: status in July 1996. PROGRESS Management Committee.
    J Hypertens Suppl; 1996 Dec; 14(6):S47-51. PubMed ID: 9023716
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Pleiotropic effects of angiotensin-converting enzyme inhibitors in normotensive patients with coronary artery disease.
    Krysiak R; Okopień B
    Pharmacol Rep; 2008; 60(4):514-23. PubMed ID: 18799820
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack.
    PROGRESS Collaborative Group
    Lancet; 2001 Sep; 358(9287):1033-41. PubMed ID: 11589932
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Perindopril.
    Alfakih K; Hall AS
    Expert Opin Pharmacother; 2006 Jan; 7(1):63-71. PubMed ID: 16370923
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The EUROPA trial.
    Brophy JM
    Lancet; 2003 Dec; 362(9399):1936; author reply 1936-7. PubMed ID: 14667759
    [No Abstract]   [Full Text] [Related]  

  • 71. Do all patients with coronary artery disease benefit from angiotensin converting enzyme inhibitors?
    Shah AD; Arora RR
    J Cardiovasc Pharmacol Ther; 2005 Dec; 10(4):281-3. PubMed ID: 16382264
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Scientific value of the EUROPA Study: mechanisms of beneficial effect of perindopril in atherosclerosis].
    Karpov IuA
    Kardiologiia; 2005; 45(2):86-9. PubMed ID: 15798719
    [No Abstract]   [Full Text] [Related]  

  • 73. Coronary calcium significantly affects quantitative analysis of coronary ultrasound: importance for atherosclerosis progression/regression studies.
    Bruining N; de Winter S; Roelandt JR; Rodriguez-Granillo GA; Heller I; van Domburg RT; Hamers R; de Feijter PJ;
    Coron Artery Dis; 2009 Sep; 20(6):409-14. PubMed ID: 19641457
    [TBL] [Abstract][Full Text] [Related]  

  • 74. New pathophysiological insights explain life-saving benefits of perindopril in coronary artery disease patients.
    Cardiovasc J S Afr; 2004; 15(5):248-9. PubMed ID: 15483736
    [No Abstract]   [Full Text] [Related]  

  • 75. [An effect of perindopril on the level of tumor necrosis factor-alpha and matrix metalloproteinase-9 in peripheral blood in the acute period of atherothrombotic ischemic stroke and myocardial infarction].
    Konstantinova EV; Shurdumova MKh; Eremin II; Shostak NA; Skvortsova VI
    Zh Nevrol Psikhiatr Im S S Korsakova; 2008; Suppl 23():15-20. PubMed ID: 19425365
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Towards the optimal management in 2004 of patients with stable coronary artery disease].
    Solignac M
    Presse Med; 2004 Sep; 33(16):1074-6. PubMed ID: 15523259
    [No Abstract]   [Full Text] [Related]  

  • 77. The incidence of all-cause, cardiovascular and respiratory disease admission among 20,252 users of lisinopril vs. perindopril: A cohort study.
    Wong MC; Chan DK; Wang HH; Tam WW; Cheung CS; Yan BP; Coats AJ
    Int J Cardiol; 2016 Sep; 219():410-6. PubMed ID: 27362832
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Perindopril improves six minute walking distance in older patients with left ventricular systolic dysfunction: a randomised double blind placebo controlled trial.
    Hutcheon SD; Gillespie ND; Crombie IK; Struthers AD; McMurdo ME
    Heart; 2002 Oct; 88(4):373-7. PubMed ID: 12231595
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Pharmacogenetic Risk Scores for Perindopril Clinical and Cost Effectiveness in Stable Coronary Artery Disease: When Are We Ready to Implement?
    Luzum JA; Lanfear DE
    J Am Heart Assoc; 2016 Mar; 5(3):e003440. PubMed ID: 27021567
    [No Abstract]   [Full Text] [Related]  

  • 80. The Effects of a Perindopril-Based Regimen in Relation to Statin Use on the Outcomes of Patients with Vascular Disease: a Combined Analysis of the ADVANCE, EUROPA, and PROGRESS Trials.
    Radhoe SP; Boersma E; Bertrand M; Remme W; Ferrari R; Fox K; MacMahon S; Chalmers J; Simoons ML; Brugts JJ
    Cardiovasc Drugs Ther; 2024 Feb; 38(1):131-139. PubMed ID: 36194352
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.